M. Roumiguié

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study

Arjun Vasant Balar, Ashish M. Kamat, Girish S. Kulkarni et al. · The Lancet Oncology · 2021 · 533 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies

Giorgio Gandaglia, Guillaume Ploussard, Massimo Valério et al. · European Urology · 2018 · 315 citations · Full text

Medicine, Oncology, Urology +17

Ureteral and Multifocal Tumours Have Worse Prognosis than Renal Pelvic Tumours in Urothelial Carcinoma of the Upper Urinary Tract Treated by Nephroureterectomy

A. Ouzzane, Pierre Colin, Évanguelos Xylinas et al. · European Urology · 2011 · 170 citations

Medicine, Oncology, Urology +16

The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging–targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy

Giorgio Gandaglia, Guillaume Ploussard, Massimo Valério et al. · European Urology · 2019 · 129 citations

Medicine, Oncology, Urology +17

Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC)

Maria Vassilakopoulou, Thibault De La Motte Rouge, Pierre Colin et al. · Cancer · 2011 · 114 citations

Medicine, Oncology, Surgery +17